The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration.
China's commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response. This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection. A preventive HIV vaccine would add a powerful tool to China's response, even if not 100% efficacious or available to the full population.
International AIDS Vaccine Initiative, 125 Broad St., 9th Floor, New York, NY 10004, USA. tharmon@iavi.org.
Thomas
T
Harmon
Chinese National Center for AIDS/STD Control and Prevention (NCAIDS), Beijing 102206, China. guowei@chinaaids.cn.
Wei
W
Guo
Futures Institute, Glastonbury, CT 06033, USA. Jstover@FuturesInstitute.org.
John
J
Stover
Chinese National Center for AIDS/STD Control and Prevention (NCAIDS), Beijing 102206, China. wuzunyou@chinaaids.cn.
Zunyou
Z
Wu
Columbia University Global Centers, East Asia, Beijing 100080, China. jak2241@columbia.edu.
Joan
J
Kaufman
PATH, Seattle, WA 98121, USA. kschneider@path.org.
Kammerle
K
Schneider
Center for Disease Control and Prevention of Sichuan Province, Chengdu 610041, China. liulir@163.com.
Li
L
Liu
Center for Disease Control and Prevention of Sichuan Province, Chengdu 610041, China. fengliao1211@aliyun.com.
Liao
L
Feng
Joint United Nations Programme for HIV/AIDS (UNAIDS), Geneva CH-1211, Switzerland. schwartlanderb@wpro.who.int.
Bernard
B
Schwartländer
China; HIV/AIDS; Sichuan; modeling; prevention; research; vaccines